MedTrace Logo

Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin

NCT01096940 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2010-11-08

No results posted yet for this study

Summary

To assess the pharmacokinetics of AZD1656 during coadministration with Simvastatin.

Conditions

Interventions

DRUG

AZD1656

Oral tablet, BID dose

DRUG

simvastatin

Oral tablet, single dose

Sponsors & Collaborators

Principal Investigators

  • Jolene K. Berg, MD · Cetero Research, Inc.

  • Stanko Skrtic · AstraZeneca

  • Mirjana Kujacic · AstraZeneca

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096940 on ClinicalTrials.gov